Cerus Investor Relations Material
Latest events
Q1 2025
Cerus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cerus Corporation
Access all reports
Cerus Corporation develops and markets blood safety technologies intended to reduce the risk of transfusion-transmitted infections. Its INTERCEPT platform is used to treat blood components such as platelets and plasma. The company serves blood centers, hospitals, and transfusion services. The company is headquartered in Concord, California, and its shares are listed on the NASDAQ.
Key slides for Cerus Corporation
Q3 2024
Cerus Corporation
Corporate Presentation
Cerus Corporation
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CERS
Country
🇺🇸 United States